New: NCI-funded clinical trial search
Mednet Logo

How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?

In light of the 4/2024 JCO publication by Peng et al., PMID 38215354
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · University of North Carolina
Answered on

This is a very interesting study and I am excited to see continued studies into symptom mitigation for definitive chemoRT.

I currently offer Ssk12 to my patients undergoing H+N RT (definitive or adjuvant). I see little potential downside as it is a relatively inexpensive intervention and they report minimal side effects in the study.

My one primary concern is the formulation. The specific brand used in the study is currently out of stock on Amazon (and elsewhere online) and while there are other brands available, I am somewhat skeptical of the QA/QC of the myriad of supplement brands on online retailers and if there are meaningful differences in the probiotic composition between brands.

Join for free or sign in to see the full answer